BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 596978)

  • 1. The effect of quinidine, propranolol and their combination on experimental atrial and ventricular arrhythmias.
    Lawson JH; Wojciechowski NJ
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):235-43. PubMed ID: 596978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of quinidine and propranolol in experimental cardiac arrhythmias in the dog.
    Madan BR; Pendse VK
    Arch Int Pharmacodyn Ther; 1977 Feb; 225(2):287-93. PubMed ID: 849075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative antiarrhythmic activity of quinidine combined with propranolol and with sotalol.
    Lawson JW; Wojciechowski NJ
    Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):72-86. PubMed ID: 6111984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the combination of quinidine and propranolol upon atrial and ventricular automatically in dogs.
    Korte DW; Nash CB
    J Pharmacol Exp Ther; 1978 Feb; 204(2):303-11. PubMed ID: 340642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of some antiarrhythmic drugs in right- or left-sided aconitine-induced experimental atrial arrhythmias.
    Gautam CS; Lal R; Pandhi P; Sharma PL
    Methods Find Exp Clin Pharmacol; 1987 Feb; 9(2):91-3. PubMed ID: 3586773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of selected antiarrhythmic drugs on coronary artery ligation-induced ventricular arrhythmias on the right or left sides.
    Gautam CS; Sharma PL; Pandhi P
    Methods Find Exp Clin Pharmacol; 1995 Jun; 17(5):327-31. PubMed ID: 8830201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the antiarrhythmic activity of quinidine and quinine.
    Klevans LR; Kelly RJ; Kovacs JL
    Arch Int Pharmacodyn Ther; 1977 May; 227(1):57-68. PubMed ID: 901074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular electrophysiology of quinidine-propranolol combinations in the dog heart.
    Korte DW; Nash CB
    J Pharmacol Exp Ther; 1976 May; 197(2):452-7. PubMed ID: 1271287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
    Weissenburger J; Davy JM; Chézalviel F; Ertzbischoff O; Poirier JM; Engel F; Lainée P; Penin E; Motté G; Cheymol G
    J Pharmacol Exp Ther; 1991 Nov; 259(2):871-83. PubMed ID: 1941633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of some beta adrenergic blocking agents and phenytoin on potentiation of quinidine antiarrhythmic activity in the mouse.
    Lawson JW
    Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):106-15. PubMed ID: 6149731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.
    Nakayama K; Oshima T; Koike H
    Jpn J Pharmacol; 1979 Dec; 29(6):935-45. PubMed ID: 44326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 4 antiarrhythmic drugs on sinoatrial conduction time in isolated and blood-perfused dog atria.
    Shimotori M; Kobayashi M; Chiba S
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):67-79. PubMed ID: 6721625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of quinidine-propranolol elevation of the ventricular fibrillation threshold by bilateral stellectomy+vagotomy in the anesthetized dog.
    Lawson JW
    Arch Int Pharmacodyn Ther; 1986 Mar; 280(1):74-83. PubMed ID: 3718083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A microelectrophysiological analysis of the pharmacodynamic basis for quinidine-propranolol antiarrhythmic potentiation.
    Iansmith DH; Bandura JP; Nash CB
    J Pharmacol Exp Ther; 1981 Dec; 219(3):651-8. PubMed ID: 7299688
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
    Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cardiac antiarrhythmic screening test in the rat: the effects of lidocaine, propranolol and quinidine.
    Baker T; Erker EF
    Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):97-102. PubMed ID: 7387264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined action of anti-arrhythmia agents].
    Gendenshteĭn EI; Kostin IaV; Balashov VP; Oleĭnikov VE
    Biull Eksp Biol Med; 1991 Jun; 111(6):623-5. PubMed ID: 1893190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of the atrium-specific positive inotropic activities of quinidine- and atropine-like agents in rats.
    Deng XF; Mulay S; Chemtob S; Varma DR
    J Pharmacol Exp Ther; 1997 Apr; 281(1):322-9. PubMed ID: 9103513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidine.
    Parmley WW; Braunwald E
    J Pharmacol Exp Ther; 1967 Oct; 158(1):11-21. PubMed ID: 6054071
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of several new antiarrhythmic agents on atrial contractility.
    Covino BG; Shannon CM
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):185-92. PubMed ID: 5353470
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.